Everest Medicines Reports 1H 2026 Results, Enters New Phase as Growth Accelerates and Innovation Gains Momentum
Aurentis Capital Group Announces Technology-Driven Trading Platform for Global Markets
TMX Group Limited Completes Acquisition of RAFI Indices from Research Affiliates
Focus Graphite Chairman Converts Final C$835,000 Loan to Equity at a Premium to Market
Hong Kong emerges as top professional services platform for Mainland enterprises going global
REDUCE-IT® patients experienced substantial cardiovascular (CV) risk reduction with icosapent ethyl regardless of the presence…
– Reported 50% response rate in visual sensitivity among patients in highest dose groups in…
– ANX005 Huntington’s Disease Phase 2 trial fully enrolled with data anticipated 2H 2021 –…
COPENHAGEN, Denmark, May 17, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
BURLINGAME, Calif., May 17, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq:…
Kathleen Lynch has joined as Head of Global Government Affairs and Communications and Michele Farmer has…
– Recent New Drug Application Resubmission for XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) – –…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage…
KIN-2787 is the company’s RAF inhibitor candidate for patients with mutant BRAF-driven solid tumors Planned…
FLT190 Phase 1/2 dose-finding study in Fabry disease on track to dose additional patients; Company to…
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., May 17, 2021…
The National Institute of Allergy and Infectious Diseases will fund the continued clinical development of…
CAMBRIDGE, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
NEWTON, Mass., May 17, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Advancing two lead product candidates in Phase 1/2 clinical trials Completed successful $126M initial public…
Advicenne receives positive feedback from the US FDA on pathway to approval and amended Phase…
Advicenne reçoit un avis positif de la FDA sur la procédure d’approbation et l’Agence accepte…